Summary of Study ST001090
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000729. The data can be accessed directly via it's Project DOI: 10.21228/M8FM38 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST001090 |
| Study Title | NMR metabolomics study of Gemcitabine resistant cancer cells |
| Study Type | NMR metabolomics |
| Study Summary | 1D 1H NMR spectra were collected from the samples and analyzed using MVAPACK software (http://bionmr.unl.edu/mvapack.php). Multivariate analysis was conducted to study the metabolic phenotypes of the samples. |
| Institute | University of Nebraska-Lincoln |
| Department | Chemistry |
| Laboratory | Dr. Robert Powers and Pankaj Singh labs |
| Last Name | Gebregiworgis |
| First Name | Teklab |
| Address | 552 Hamilton Hall, 639 N. 12th Street, Lincoln, NE, 68588, USA |
| teklab@huskers.unl.edu | |
| Phone | (402) 472-3039 |
| Submit Date | 2018-09-25 |
| Raw Data File Type(s) | fid |
| Analysis Type Detail | NMR |
| Release Date | 2019-10-11 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR000729 |
| Project DOI: | doi: 10.21228/M8FM38 |
| Project Title: | NMR metabolomics study of Gemcitabine resistant cancer cells |
| Project Type: | NMR metabolomics |
| Project Summary: | 1D 1H NMR based differential metabolomics study of T3M4 cells, which are gemcitabine sensitive, and gemcitabine resistant T3M4 cells (GemR) were cultured with or without gemcitabine treatment. 1D 1H NMR spectra were collected from the samples and analyzed using MVAPACK software (http://bionmr.unl.edu/mvapack.php). Using multivariate analysis, unique responses to gemcitabine treatment were revealed, which may be useful in the clinical setting for monitoring a patient’s therapeutic response. |
| Institute: | University of Nebraska-Lincoln |
| Department: | Chemistry |
| Laboratory: | Robert Powers and Pankaj Singh labs |
| Last Name: | Gebregiworgis |
| First Name: | Teklab |
| Address: | 552 Hamilton Hall, 639 N. 12th Street, Lincoln, NE, 68588, USA |
| Email: | teklab@huskers.unl.edu |
| Phone: | (402) 472-3039 |
| Funding Source: | NCI, NIGMS, AACR |
| Contributors: | Teklab Gebregiworgis, Fatema Bhinderwala, Vinee Purohit, Nina V. Chaika, Pankaj K. Singh, and Robert Powers |
